Walleye Trading
IRON icon

Walleye Trading’s Disc Medicine IRON Stock Holding History

Walleye Trading’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-343
Closed -$14K – 5386
2022
Q1 		$14K Sell
343
-146
-30% -$7.66K ﹤0.01% 4844
2021
Q4 		$43K Buy
489
+87
+22% +$8.53K ﹤0.01% 4717
2021
Q3 		$49K Sell
402
-359
-47% -$49.1K ﹤0.01% 4640
2021
Q2 		$148K Buy
+761
New +$250K ﹤0.01% 4164

Other funds holding IRON

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Walleye Trading's IRON Position: Q2 2022 in Review

Walleye Trading sold out of Disc Medicine (IRON) in Q2 2022, closing a stake of 343 shares — an estimated $14K sold.

Walleye Trading first reported a position in IRON in Q2 2021 and held it in 4 quarters. The position peaked at $148K in Q2 2021. 50 funds tracked by Wall St. Rank hold IRON as of Q2 2022.

  • Walleye Trading reported no remaining Disc Medicine position as of Q2 2022 after selling out during the quarter.
  • Walleye Trading sold 343 Disc Medicine shares in Q2 2022, an estimated $14K.
  • Walleye Trading first reported a position in Disc Medicine in Q2 2021 and held it in 4 quarters.
  • Walleye Trading's Disc Medicine position peaked at $148K in Q2 2021.
  • 50 funds tracked by Wall St. Rank held Disc Medicine as of Q2 2022.

Based on Walleye Trading's 13F filing for Q2 2022, filed 8 Aug 2022.